nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—BMPR2—hypertension	0.138	0.312	CbGaD
Bosutinib—PTK2—hypertension	0.0998	0.226	CbGaD
Bosutinib—RPS6KB1—hypertension	0.0814	0.184	CbGaD
Bosutinib—PDGFRB—hypertension	0.0524	0.119	CbGaD
Bosutinib—SRC—hypertension	0.0423	0.0956	CbGaD
Bosutinib—EGFR—hypertension	0.0284	0.0643	CbGaD
Bosutinib—ABCB1—Nadolol—hypertension	0.00585	0.0424	CbGbCtD
Bosutinib—ABCB1—Acebutolol—hypertension	0.00535	0.0388	CbGbCtD
Bosutinib—ABCB1—Metoprolol—hypertension	0.00497	0.036	CbGbCtD
Bosutinib—ABCB1—Candesartan—hypertension	0.00497	0.036	CbGbCtD
Bosutinib—ABCB1—Terazosin—hypertension	0.00467	0.0339	CbGbCtD
Bosutinib—CYP3A4—Guanethidine—hypertension	0.00462	0.0335	CbGbCtD
Bosutinib—ABCB1—Reserpine—hypertension	0.00443	0.0321	CbGbCtD
Bosutinib—ABCB1—Perindopril—hypertension	0.00405	0.0294	CbGbCtD
Bosutinib—ABCB1—Doxazosin—hypertension	0.0039	0.0283	CbGbCtD
Bosutinib—ABCB1—Nisoldipine—hypertension	0.0039	0.0283	CbGbCtD
Bosutinib—ABCB1—Diltiazem—hypertension	0.00377	0.0273	CbGbCtD
Bosutinib—ABCB1—Telmisartan—hypertension	0.00354	0.0257	CbGbCtD
Bosutinib—CYP3A4—Hydralazine—hypertension	0.0035	0.0254	CbGbCtD
Bosutinib—ABCB1—Bepridil—hypertension	0.00336	0.0243	CbGbCtD
Bosutinib—ABCB1—Lisinopril—hypertension	0.00336	0.0243	CbGbCtD
Bosutinib—ABCB1—Enalapril—hypertension	0.00336	0.0243	CbGbCtD
Bosutinib—ABCB1—Prazosin—hypertension	0.0032	0.0232	CbGbCtD
Bosutinib—ABCB1—Amlodipine—hypertension	0.00301	0.0218	CbGbCtD
Bosutinib—CYP3A4—Guanfacine—hypertension	0.00298	0.0216	CbGbCtD
Bosutinib—ABCB1—Spironolactone—hypertension	0.00296	0.0214	CbGbCtD
Bosutinib—ABCB1—Felodipine—hypertension	0.0029	0.021	CbGbCtD
Bosutinib—ABCB1—Timolol—hypertension	0.00285	0.0207	CbGbCtD
Bosutinib—ABCB1—Nifedipine—hypertension	0.00281	0.0204	CbGbCtD
Bosutinib—ABCB1—Nicardipine—hypertension	0.00276	0.02	CbGbCtD
Bosutinib—ABCB1—Carvedilol—hypertension	0.00276	0.02	CbGbCtD
Bosutinib—CYP3A4—Isradipine—hypertension	0.00265	0.0192	CbGbCtD
Bosutinib—ABCB1—Propranolol—hypertension	0.00254	0.0184	CbGbCtD
Bosutinib—ABCB1—Captopril—hypertension	0.00251	0.0182	CbGbCtD
Bosutinib—ABCB1—Clonidine—hypertension	0.00243	0.0176	CbGbCtD
Bosutinib—CYP3A4—Nisoldipine—hypertension	0.00234	0.0169	CbGbCtD
Bosutinib—CYP3A4—Indapamide—hypertension	0.00234	0.0169	CbGbCtD
Bosutinib—CYP3A4—Diltiazem—hypertension	0.00226	0.0164	CbGbCtD
Bosutinib—CYP3A4—Eplerenone—hypertension	0.00226	0.0164	CbGbCtD
Bosutinib—ABCB1—Atorvastatin—hypertension	0.00216	0.0157	CbGbCtD
Bosutinib—CYP3A4—Enalapril—hypertension	0.00201	0.0146	CbGbCtD
Bosutinib—ABCB1—Losartan—hypertension	0.00198	0.0143	CbGbCtD
Bosutinib—CYP3A4—Irbesartan—hypertension	0.00184	0.0133	CbGbCtD
Bosutinib—CYP3A4—Amlodipine—hypertension	0.0018	0.0131	CbGbCtD
Bosutinib—ABCB1—Verapamil—hypertension	0.00175	0.0127	CbGbCtD
Bosutinib—CYP3A4—Felodipine—hypertension	0.00174	0.0126	CbGbCtD
Bosutinib—CYP3A4—Nifedipine—hypertension	0.00168	0.0122	CbGbCtD
Bosutinib—CYP3A4—Carvedilol—hypertension	0.00166	0.012	CbGbCtD
Bosutinib—CYP3A4—Nicardipine—hypertension	0.00166	0.012	CbGbCtD
Bosutinib—CYP3A4—Propranolol—hypertension	0.00152	0.0111	CbGbCtD
Bosutinib—CYP3A4—Clonidine—hypertension	0.00145	0.0105	CbGbCtD
Bosutinib—CYP3A4—Atorvastatin—hypertension	0.0013	0.0094	CbGbCtD
Bosutinib—CYP3A4—Losartan—hypertension	0.00119	0.00859	CbGbCtD
Bosutinib—CYP3A4—Verapamil—hypertension	0.00105	0.00758	CbGbCtD
Bosutinib—Vandetanib—PDGFRB—hypertension	0.000485	0.165	CrCbGaD
Bosutinib—Vandetanib—SRC—hypertension	0.000391	0.133	CrCbGaD
Bosutinib—Vandetanib—KDR—hypertension	0.000367	0.125	CrCbGaD
Bosutinib—Vandetanib—ABCC1—hypertension	0.000364	0.124	CrCbGaD
Bosutinib—Vandetanib—VEGFA—hypertension	0.000311	0.106	CrCbGaD
Bosutinib—BTK—Treprostinil—Nadolol—hypertension	0.0003	0.121	CbGdCrCtD
Bosutinib—Vandetanib—EGFR—hypertension	0.000263	0.0892	CrCbGaD
Bosutinib—Gefitinib—EGFR—hypertension	0.00025	0.0847	CrCbGaD
Bosutinib—Gefitinib—CYP3A5—hypertension	0.000211	0.0715	CrCbGaD
Bosutinib—CASK—Pitavastatin—Atorvastatin—hypertension	0.000194	0.0785	CbGdCrCtD
Bosutinib—PTK2B—Pindolol—Nadolol—hypertension	0.00015	0.0609	CbGdCrCtD
Bosutinib—MAP4K4—Testosterone Propionate—Eplerenone—hypertension	0.000144	0.0582	CbGdCrCtD
Bosutinib—Gefitinib—CYP1A1—hypertension	0.000143	0.0485	CrCbGaD
Bosutinib—PTK2B—Pindolol—Acebutolol—hypertension	0.000132	0.0536	CbGdCrCtD
Bosutinib—MAP4K4—Testosterone Propionate—Spironolactone—hypertension	0.000125	0.0506	CbGdCrCtD
Bosutinib—PTK2B—Pindolol—Metoprolol—hypertension	0.00012	0.0487	CbGdCrCtD
Bosutinib—ERBB3—Alprenolol—Acebutolol—hypertension	0.00012	0.0486	CbGdCrCtD
Bosutinib—PTK2B—Pindolol—Esmolol—hypertension	0.000114	0.0461	CbGdCrCtD
Bosutinib—ERBB3—Alprenolol—Metoprolol—hypertension	0.000109	0.0442	CbGdCrCtD
Bosutinib—ERBB3—Alprenolol—Esmolol—hypertension	0.000103	0.0419	CbGdCrCtD
Bosutinib—CSK—Treprostinil—Nadolol—hypertension	0.000102	0.0415	CbGdCrCtD
Bosutinib—ERBB3—Alprenolol—Pindolol—hypertension	0.000101	0.0409	CbGdCrCtD
Bosutinib—PTK2B—Pindolol—Betaxolol—hypertension	0.0001	0.0406	CbGdCrCtD
Bosutinib—ERBB3—Alprenolol—Penbutolol—hypertension	9.86e-05	0.0399	CbGdCrCtD
Bosutinib—EPHB4—cardiovascular system—hypertension	9.65e-05	0.00099	CbGeAlD
Bosutinib—AXL—cortex of kidney—hypertension	9.62e-05	0.000987	CbGeAlD
Bosutinib—TBK1—cardiac atrium—hypertension	9.61e-05	0.000986	CbGeAlD
Bosutinib—CAMK1D—central nervous system—hypertension	9.6e-05	0.000986	CbGeAlD
Bosutinib—HCK—adrenal gland—hypertension	9.6e-05	0.000986	CbGeAlD
Bosutinib—CLK1—adrenal gland—hypertension	9.6e-05	0.000986	CbGeAlD
Bosutinib—ABL2—adrenal gland—hypertension	9.54e-05	0.00098	CbGeAlD
Bosutinib—ERBB4—endocrine gland—hypertension	9.53e-05	0.000978	CbGeAlD
Bosutinib—IRAK4—medulla oblongata—hypertension	9.52e-05	0.000978	CbGeAlD
Bosutinib—SIK1—medulla oblongata—hypertension	9.52e-05	0.000978	CbGeAlD
Bosutinib—MAP4K5—decidua—hypertension	9.51e-05	0.000977	CbGeAlD
Bosutinib—MAP3K3—decidua—hypertension	9.51e-05	0.000977	CbGeAlD
Bosutinib—STK24—central nervous system—hypertension	9.49e-05	0.000974	CbGeAlD
Bosutinib—YES1—nephron tubule—hypertension	9.49e-05	0.000974	CbGeAlD
Bosutinib—EPHA2—cardiovascular system—hypertension	9.46e-05	0.000971	CbGeAlD
Bosutinib—FYN—cardiovascular system—hypertension	9.45e-05	0.00097	CbGeAlD
Bosutinib—EPHB4—kidney—hypertension	9.44e-05	0.000969	CbGeAlD
Bosutinib—EPHA4—medulla oblongata—hypertension	9.43e-05	0.000968	CbGeAlD
Bosutinib—CAMK2G—adrenal gland—hypertension	9.43e-05	0.000968	CbGeAlD
Bosutinib—BMP2K—adrenal gland—hypertension	9.43e-05	0.000968	CbGeAlD
Bosutinib—ROCK1—endocrine gland—hypertension	9.4e-05	0.000965	CbGeAlD
Bosutinib—ABL1—cardiac ventricle—hypertension	9.39e-05	0.000964	CbGeAlD
Bosutinib—TAOK3—nephron tubule—hypertension	9.37e-05	0.000962	CbGeAlD
Bosutinib—LRRK2—adrenal gland—hypertension	9.34e-05	0.000959	CbGeAlD
Bosutinib—YES1—adrenal cortex—hypertension	9.34e-05	0.000959	CbGeAlD
Bosutinib—EGFR—adrenal gland—hypertension	9.31e-05	0.000956	CbGeAlD
Bosutinib—ULK3—medulla oblongata—hypertension	9.31e-05	0.000956	CbGeAlD
Bosutinib—MAP2K2—medulla oblongata—hypertension	9.31e-05	0.000956	CbGeAlD
Bosutinib—SLK—cortex of kidney—hypertension	9.26e-05	0.00095	CbGeAlD
Bosutinib—MAP2K5—brainstem—hypertension	9.24e-05	0.000949	CbGeAlD
Bosutinib—FYN—kidney—hypertension	9.24e-05	0.000949	CbGeAlD
Bosutinib—RPS6KB1—cardiac atrium—hypertension	9.24e-05	0.000948	CbGeAlD
Bosutinib—MAP3K3—cardiovascular system—hypertension	9.23e-05	0.000947	CbGeAlD
Bosutinib—TAOK3—adrenal cortex—hypertension	9.22e-05	0.000946	CbGeAlD
Bosutinib—EPHB4—cortex of kidney—hypertension	9.19e-05	0.000943	CbGeAlD
Bosutinib—EPHA5—central nervous system—hypertension	9.19e-05	0.000943	CbGeAlD
Bosutinib—TYRO3—central nervous system—hypertension	9.19e-05	0.000943	CbGeAlD
Bosutinib—FER—central nervous system—hypertension	9.19e-05	0.000943	CbGeAlD
Bosutinib—ALK—central nervous system—hypertension	9.19e-05	0.000943	CbGeAlD
Bosutinib—MAP3K7—medulla oblongata—hypertension	9.16e-05	0.00094	CbGeAlD
Bosutinib—AXL—cardiac atrium—hypertension	9.15e-05	0.000939	CbGeAlD
Bosutinib—LYN—central nervous system—hypertension	9.14e-05	0.000938	CbGeAlD
Bosutinib—BMPR2—endocrine gland—hypertension	9.13e-05	0.000938	CbGeAlD
Bosutinib—PTK2B—adrenal gland—hypertension	9.1e-05	0.000934	CbGeAlD
Bosutinib—ERBB3—Alprenolol—Betaxolol—hypertension	9.1e-05	0.0368	CbGdCrCtD
Bosutinib—STK36—endocrine gland—hypertension	9.06e-05	0.00093	CbGeAlD
Bosutinib—TBK1—medulla oblongata—hypertension	9.06e-05	0.000929	CbGeAlD
Bosutinib—YES1—heart—hypertension	9.03e-05	0.000927	CbGeAlD
Bosutinib—FYN—cortex of kidney—hypertension	9e-05	0.000924	CbGeAlD
Bosutinib—MAP3K19—central nervous system—hypertension	9e-05	0.000924	CbGeAlD
Bosutinib—YES1—smooth muscle tissue—hypertension	8.96e-05	0.00092	CbGeAlD
Bosutinib—MERTK—endocrine gland—hypertension	8.96e-05	0.000919	CbGeAlD
Bosutinib—CSNK1E—adrenal gland—hypertension	8.96e-05	0.000919	CbGeAlD
Bosutinib—STK10—heart—hypertension	8.95e-05	0.000919	CbGeAlD
Bosutinib—TAOK3—heart—hypertension	8.92e-05	0.000915	CbGeAlD
Bosutinib—ABL1—myocardium—hypertension	8.84e-05	0.000907	CbGeAlD
Bosutinib—TNK2—central nervous system—hypertension	8.83e-05	0.000906	CbGeAlD
Bosutinib—IRAK4—adrenal gland—hypertension	8.82e-05	0.000905	CbGeAlD
Bosutinib—SIK1—adrenal gland—hypertension	8.82e-05	0.000905	CbGeAlD
Bosutinib—SLK—cardiac atrium—hypertension	8.81e-05	0.000904	CbGeAlD
Bosutinib—MAP4K5—cortex of kidney—hypertension	8.8e-05	0.000903	CbGeAlD
Bosutinib—MAP3K3—cortex of kidney—hypertension	8.8e-05	0.000903	CbGeAlD
Bosutinib—MAP4K4—endocrine gland—hypertension	8.79e-05	0.000902	CbGeAlD
Bosutinib—YES1—decidua—hypertension	8.79e-05	0.000902	CbGeAlD
Bosutinib—EPHB4—cardiac atrium—hypertension	8.74e-05	0.000897	CbGeAlD
Bosutinib—BCR—endocrine gland—hypertension	8.73e-05	0.000896	CbGeAlD
Bosutinib—EPHA4—adrenal gland—hypertension	8.73e-05	0.000896	CbGeAlD
Bosutinib—RPS6KB1—medulla oblongata—hypertension	8.71e-05	0.000894	CbGeAlD
Bosutinib—STK10—decidua—hypertension	8.71e-05	0.000894	CbGeAlD
Bosutinib—SRC—heart—hypertension	8.69e-05	0.000892	CbGeAlD
Bosutinib—TAOK3—decidua—hypertension	8.67e-05	0.00089	CbGeAlD
Bosutinib—MAP3K12—endocrine gland—hypertension	8.67e-05	0.00089	CbGeAlD
Bosutinib—AXL—medulla oblongata—hypertension	8.62e-05	0.000885	CbGeAlD
Bosutinib—SRC—smooth muscle tissue—hypertension	8.62e-05	0.000885	CbGeAlD
Bosutinib—MAP2K2—adrenal gland—hypertension	8.62e-05	0.000885	CbGeAlD
Bosutinib—ULK3—adrenal gland—hypertension	8.62e-05	0.000885	CbGeAlD
Bosutinib—ERBB4—central nervous system—hypertension	8.59e-05	0.000881	CbGeAlD
Bosutinib—EPHA2—cardiac atrium—hypertension	8.58e-05	0.00088	CbGeAlD
Bosutinib—FYN—cardiac atrium—hypertension	8.56e-05	0.000879	CbGeAlD
Bosutinib—MAP3K2—adrenal gland—hypertension	8.56e-05	0.000879	CbGeAlD
Bosutinib—MAP2K1—endocrine gland—hypertension	8.49e-05	0.000872	CbGeAlD
Bosutinib—STK35—endocrine gland—hypertension	8.49e-05	0.000872	CbGeAlD
Bosutinib—MAP3K7—adrenal gland—hypertension	8.48e-05	0.00087	CbGeAlD
Bosutinib—ROCK1—central nervous system—hypertension	8.47e-05	0.00087	CbGeAlD
Bosutinib—SRC—decidua—hypertension	8.45e-05	0.000868	CbGeAlD
Bosutinib—STK10—cardiovascular system—hypertension	8.45e-05	0.000867	CbGeAlD
Bosutinib—CSK—endocrine gland—hypertension	8.44e-05	0.000866	CbGeAlD
Bosutinib—CHEK2—Pitavastatin—Atorvastatin—hypertension	8.43e-05	0.0342	CbGdCrCtD
Bosutinib—TAOK3—cardiovascular system—hypertension	8.42e-05	0.000864	CbGeAlD
Bosutinib—PTK2—adrenal gland—hypertension	8.38e-05	0.00086	CbGeAlD
Bosutinib—TBK1—adrenal gland—hypertension	8.38e-05	0.00086	CbGeAlD
Bosutinib—CSNK1A1—endocrine gland—hypertension	8.38e-05	0.00086	CbGeAlD
Bosutinib—Vandetanib—ALB—hypertension	8.37e-05	0.0284	CrCbGaD
Bosutinib—MAP3K3—cardiac atrium—hypertension	8.37e-05	0.000859	CbGeAlD
Bosutinib—MAP4K5—cardiac atrium—hypertension	8.37e-05	0.000859	CbGeAlD
Bosutinib—YES1—kidney—hypertension	8.34e-05	0.000856	CbGeAlD
Bosutinib—HCK—endocrine gland—hypertension	8.33e-05	0.000855	CbGeAlD
Bosutinib—CLK1—endocrine gland—hypertension	8.33e-05	0.000855	CbGeAlD
Bosutinib—SLK—medulla oblongata—hypertension	8.3e-05	0.000852	CbGeAlD
Bosutinib—MAP2K5—adrenal cortex—hypertension	8.27e-05	0.000848	CbGeAlD
Bosutinib—STK10—kidney—hypertension	8.27e-05	0.000848	CbGeAlD
Bosutinib—EPHB4—medulla oblongata—hypertension	8.24e-05	0.000846	CbGeAlD
Bosutinib—TAOK3—kidney—hypertension	8.23e-05	0.000845	CbGeAlD
Bosutinib—BMPR2—central nervous system—hypertension	8.23e-05	0.000845	CbGeAlD
Bosutinib—IRAK1—adrenal gland—hypertension	8.22e-05	0.000844	CbGeAlD
Bosutinib—SRC—cardiovascular system—hypertension	8.2e-05	0.000842	CbGeAlD
Bosutinib—CAMK2G—endocrine gland—hypertension	8.17e-05	0.000839	CbGeAlD
Bosutinib—BMP2K—endocrine gland—hypertension	8.17e-05	0.000839	CbGeAlD
Bosutinib—STK36—central nervous system—hypertension	8.17e-05	0.000838	CbGeAlD
Bosutinib—EPHB3—central nervous system—hypertension	8.17e-05	0.000838	CbGeAlD
Bosutinib—YES1—cortex of kidney—hypertension	8.12e-05	0.000834	CbGeAlD
Bosutinib—LRRK2—endocrine gland—hypertension	8.1e-05	0.000831	CbGeAlD
Bosutinib—MERTK—central nervous system—hypertension	8.07e-05	0.000829	CbGeAlD
Bosutinib—FYN—medulla oblongata—hypertension	8.07e-05	0.000828	CbGeAlD
Bosutinib—CSF1R—adrenal cortex—hypertension	8.07e-05	0.000828	CbGeAlD
Bosutinib—RPS6KB1—adrenal gland—hypertension	8.06e-05	0.000828	CbGeAlD
Bosutinib—SRC—kidney—hypertension	8.02e-05	0.000824	CbGeAlD
Bosutinib—TAOK3—cortex of kidney—hypertension	8.02e-05	0.000823	CbGeAlD
Bosutinib—FGR—adrenal gland—hypertension	8.02e-05	0.000823	CbGeAlD
Bosutinib—LCK—adrenal gland—hypertension	8.02e-05	0.000823	CbGeAlD
Bosutinib—MAP2K5—heart—hypertension	8e-05	0.000821	CbGeAlD
Bosutinib—AXL—adrenal gland—hypertension	7.98e-05	0.000819	CbGeAlD
Bosutinib—Gefitinib—ALB—hypertension	7.95e-05	0.027	CrCbGaD
Bosutinib—MAP4K4—central nervous system—hypertension	7.92e-05	0.000813	CbGeAlD
Bosutinib—PTK2B—endocrine gland—hypertension	7.89e-05	0.00081	CbGeAlD
Bosutinib—MAP4K5—medulla oblongata—hypertension	7.89e-05	0.00081	CbGeAlD
Bosutinib—MAP3K3—medulla oblongata—hypertension	7.89e-05	0.00081	CbGeAlD
Bosutinib—BCR—central nervous system—hypertension	7.87e-05	0.000807	CbGeAlD
Bosutinib—MAP3K12—central nervous system—hypertension	7.81e-05	0.000802	CbGeAlD
Bosutinib—CSF1R—heart—hypertension	7.8e-05	0.000801	CbGeAlD
Bosutinib—MAP2K5—decidua—hypertension	7.78e-05	0.000798	CbGeAlD
Bosutinib—CSNK1E—endocrine gland—hypertension	7.77e-05	0.000797	CbGeAlD
Bosutinib—CSF1R—smooth muscle tissue—hypertension	7.74e-05	0.000794	CbGeAlD
Bosutinib—YES1—cardiac atrium—hypertension	7.73e-05	0.000793	CbGeAlD
Bosutinib—SLK—adrenal gland—hypertension	7.68e-05	0.000789	CbGeAlD
Bosutinib—MAP2K1—central nervous system—hypertension	7.65e-05	0.000785	CbGeAlD
Bosutinib—STK35—central nervous system—hypertension	7.65e-05	0.000785	CbGeAlD
Bosutinib—SIK1—endocrine gland—hypertension	7.65e-05	0.000785	CbGeAlD
Bosutinib—EPHB4—adrenal gland—hypertension	7.63e-05	0.000783	CbGeAlD
Bosutinib—TAOK3—cardiac atrium—hypertension	7.63e-05	0.000783	CbGeAlD
Bosutinib—CSK—central nervous system—hypertension	7.6e-05	0.00078	CbGeAlD
Bosutinib—CSF1R—decidua—hypertension	7.59e-05	0.000779	CbGeAlD
Bosutinib—EPHA4—endocrine gland—hypertension	7.57e-05	0.000777	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—hypertension	7.55e-05	0.000775	CbGeAlD
Bosutinib—MAP2K5—cardiovascular system—hypertension	7.54e-05	0.000774	CbGeAlD
Bosutinib—HCK—central nervous system—hypertension	7.5e-05	0.00077	CbGeAlD
Bosutinib—CLK1—central nervous system—hypertension	7.5e-05	0.00077	CbGeAlD
Bosutinib—ERBB3—endocrine gland—hypertension	7.49e-05	0.000769	CbGeAlD
Bosutinib—CHEK2—Treprostinil—Nadolol—hypertension	7.49e-05	0.0304	CbGdCrCtD
Bosutinib—EPHA2—adrenal gland—hypertension	7.48e-05	0.000768	CbGeAlD
Bosutinib—MAP2K2—endocrine gland—hypertension	7.48e-05	0.000767	CbGeAlD
Bosutinib—ULK3—endocrine gland—hypertension	7.48e-05	0.000767	CbGeAlD
Bosutinib—FYN—adrenal gland—hypertension	7.47e-05	0.000767	CbGeAlD
Bosutinib—SRC—cardiac atrium—hypertension	7.43e-05	0.000763	CbGeAlD
Bosutinib—MAP3K2—endocrine gland—hypertension	7.42e-05	0.000762	CbGeAlD
Bosutinib—CAMK2G—central nervous system—hypertension	7.37e-05	0.000756	CbGeAlD
Bosutinib—BMP2K—central nervous system—hypertension	7.37e-05	0.000756	CbGeAlD
Bosutinib—CSF1R—cardiovascular system—hypertension	7.36e-05	0.000756	CbGeAlD
Bosutinib—MAP3K3—adrenal gland—hypertension	7.3e-05	0.000749	CbGeAlD
Bosutinib—MAP4K5—adrenal gland—hypertension	7.3e-05	0.000749	CbGeAlD
Bosutinib—LRRK2—central nervous system—hypertension	7.3e-05	0.000749	CbGeAlD
Bosutinib—YES1—medulla oblongata—hypertension	7.28e-05	0.000748	CbGeAlD
Bosutinib—PTK2—endocrine gland—hypertension	7.27e-05	0.000746	CbGeAlD
Bosutinib—TBK1—endocrine gland—hypertension	7.27e-05	0.000746	CbGeAlD
Bosutinib—TAOK3—medulla oblongata—hypertension	7.19e-05	0.000738	CbGeAlD
Bosutinib—MAP2K5—cortex of kidney—hypertension	7.19e-05	0.000738	CbGeAlD
Bosutinib—PDGFRB—adrenal cortex—hypertension	7.16e-05	0.000734	CbGeAlD
Bosutinib—ABL1—brainstem—hypertension	7.13e-05	0.000732	CbGeAlD
Bosutinib—PTK2B—central nervous system—hypertension	7.11e-05	0.00073	CbGeAlD
Bosutinib—CSNK1E—central nervous system—hypertension	7e-05	0.000718	CbGeAlD
Bosutinib—RPS6KB1—endocrine gland—hypertension	6.99e-05	0.000718	CbGeAlD
Bosutinib—FGR—endocrine gland—hypertension	6.95e-05	0.000713	CbGeAlD
Bosutinib—AXL—endocrine gland—hypertension	6.92e-05	0.000711	CbGeAlD
Bosutinib—PDGFRB—heart—hypertension	6.92e-05	0.00071	CbGeAlD
Bosutinib—SIK1—central nervous system—hypertension	6.89e-05	0.000707	CbGeAlD
Bosutinib—IRAK4—central nervous system—hypertension	6.89e-05	0.000707	CbGeAlD
Bosutinib—PDGFRB—smooth muscle tissue—hypertension	6.87e-05	0.000705	CbGeAlD
Bosutinib—MAP2K5—cardiac atrium—hypertension	6.84e-05	0.000702	CbGeAlD
Bosutinib—EPHA4—central nervous system—hypertension	6.82e-05	0.0007	CbGeAlD
Bosutinib—PTK2B—Pindolol—Propranolol—hypertension	6.8e-05	0.0276	CbGdCrCtD
Bosutinib—ERBB3—central nervous system—hypertension	6.75e-05	0.000693	CbGeAlD
Bosutinib—YES1—adrenal gland—hypertension	6.74e-05	0.000692	CbGeAlD
Bosutinib—ULK3—central nervous system—hypertension	6.74e-05	0.000691	CbGeAlD
Bosutinib—MAP2K2—central nervous system—hypertension	6.74e-05	0.000691	CbGeAlD
Bosutinib—PDGFRB—decidua—hypertension	6.73e-05	0.000691	CbGeAlD
Bosutinib—MAP3K2—central nervous system—hypertension	6.69e-05	0.000687	CbGeAlD
Bosutinib—STK10—adrenal gland—hypertension	6.68e-05	0.000686	CbGeAlD
Bosutinib—CSF1R—cardiac atrium—hypertension	6.67e-05	0.000685	CbGeAlD
Bosutinib—TAOK3—adrenal gland—hypertension	6.66e-05	0.000683	CbGeAlD
Bosutinib—EPHB4—endocrine gland—hypertension	6.62e-05	0.000679	CbGeAlD
Bosutinib—PTK2—central nervous system—hypertension	6.55e-05	0.000672	CbGeAlD
Bosutinib—TBK1—central nervous system—hypertension	6.55e-05	0.000672	CbGeAlD
Bosutinib—PDGFRB—cardiovascular system—hypertension	6.53e-05	0.00067	CbGeAlD
Bosutinib—EPHA2—endocrine gland—hypertension	6.49e-05	0.000666	CbGeAlD
Bosutinib—SRC—adrenal gland—hypertension	6.49e-05	0.000666	CbGeAlD
Bosutinib—ABL1—nephron tubule—hypertension	6.48e-05	0.000665	CbGeAlD
Bosutinib—FYN—endocrine gland—hypertension	6.48e-05	0.000665	CbGeAlD
Bosutinib—MAP2K5—medulla oblongata—hypertension	6.45e-05	0.000662	CbGeAlD
Bosutinib—PDGFRB—kidney—hypertension	6.39e-05	0.000656	CbGeAlD
Bosutinib—ABL1—adrenal cortex—hypertension	6.38e-05	0.000655	CbGeAlD
Bosutinib—MAP3K3—endocrine gland—hypertension	6.33e-05	0.00065	CbGeAlD
Bosutinib—MAP4K5—endocrine gland—hypertension	6.33e-05	0.00065	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—hypertension	6.3e-05	0.000647	CbGeAlD
Bosutinib—CSF1R—medulla oblongata—hypertension	6.29e-05	0.000646	CbGeAlD
Bosutinib—FGR—central nervous system—hypertension	6.26e-05	0.000643	CbGeAlD
Bosutinib—AXL—central nervous system—hypertension	6.24e-05	0.00064	CbGeAlD
Bosutinib—PDGFRB—cortex of kidney—hypertension	6.22e-05	0.000639	CbGeAlD
Bosutinib—ERBB3—Alprenolol—Propranolol—hypertension	6.17e-05	0.025	CbGdCrCtD
Bosutinib—ABL1—heart—hypertension	6.17e-05	0.000633	CbGeAlD
Bosutinib—ABL1—smooth muscle tissue—hypertension	6.12e-05	0.000628	CbGeAlD
Bosutinib—ABL1—decidua—hypertension	6e-05	0.000616	CbGeAlD
Bosutinib—MAP2K5—adrenal gland—hypertension	5.97e-05	0.000612	CbGeAlD
Bosutinib—PDGFRB—cardiac atrium—hypertension	5.92e-05	0.000607	CbGeAlD
Bosutinib—EPHA2—central nervous system—hypertension	5.85e-05	0.0006	CbGeAlD
Bosutinib—YES1—endocrine gland—hypertension	5.85e-05	0.0006	CbGeAlD
Bosutinib—FYN—central nervous system—hypertension	5.84e-05	0.000599	CbGeAlD
Bosutinib—CSF1R—adrenal gland—hypertension	5.82e-05	0.000598	CbGeAlD
Bosutinib—ABL1—cardiovascular system—hypertension	5.82e-05	0.000597	CbGeAlD
Bosutinib—STK10—endocrine gland—hypertension	5.79e-05	0.000595	CbGeAlD
Bosutinib—TAOK3—endocrine gland—hypertension	5.77e-05	0.000592	CbGeAlD
Bosutinib—MAP4K5—central nervous system—hypertension	5.71e-05	0.000586	CbGeAlD
Bosutinib—MAP3K3—central nervous system—hypertension	5.71e-05	0.000586	CbGeAlD
Bosutinib—ABL1—kidney—hypertension	5.69e-05	0.000584	CbGeAlD
Bosutinib—SRC—endocrine gland—hypertension	5.63e-05	0.000577	CbGeAlD
Bosutinib—PDGFRB—medulla oblongata—hypertension	5.58e-05	0.000573	CbGeAlD
Bosutinib—ABL1—cortex of kidney—hypertension	5.55e-05	0.000569	CbGeAlD
Bosutinib—ABL1—cardiac atrium—hypertension	5.28e-05	0.000541	CbGeAlD
Bosutinib—YES1—central nervous system—hypertension	5.27e-05	0.000541	CbGeAlD
Bosutinib—STK10—central nervous system—hypertension	5.22e-05	0.000536	CbGeAlD
Bosutinib—TAOK3—central nervous system—hypertension	5.2e-05	0.000534	CbGeAlD
Bosutinib—MAP2K5—endocrine gland—hypertension	5.17e-05	0.000531	CbGeAlD
Bosutinib—PDGFRB—adrenal gland—hypertension	5.16e-05	0.00053	CbGeAlD
Bosutinib—SRC—central nervous system—hypertension	5.07e-05	0.00052	CbGeAlD
Bosutinib—CSF1R—endocrine gland—hypertension	5.05e-05	0.000518	CbGeAlD
Bosutinib—ABL1—medulla oblongata—hypertension	4.97e-05	0.00051	CbGeAlD
Bosutinib—MAP2K5—central nervous system—hypertension	4.66e-05	0.000479	CbGeAlD
Bosutinib—ABL1—adrenal gland—hypertension	4.6e-05	0.000472	CbGeAlD
Bosutinib—CSF1R—central nervous system—hypertension	4.55e-05	0.000467	CbGeAlD
Bosutinib—PDGFRB—endocrine gland—hypertension	4.48e-05	0.00046	CbGeAlD
Bosutinib—ABCB1—blood vessel—hypertension	4.06e-05	0.000416	CbGeAlD
Bosutinib—PDGFRB—central nervous system—hypertension	4.04e-05	0.000414	CbGeAlD
Bosutinib—CHEK2—Testosterone Propionate—Eplerenone—hypertension	4.03e-05	0.0163	CbGdCrCtD
Bosutinib—ABL1—endocrine gland—hypertension	3.99e-05	0.00041	CbGeAlD
Bosutinib—ABL1—central nervous system—hypertension	3.6e-05	0.000369	CbGeAlD
Bosutinib—CHEK2—Testosterone Propionate—Spironolactone—hypertension	3.51e-05	0.0142	CbGdCrCtD
Bosutinib—Headache—Carvedilol—hypertension	2.9e-05	0.000194	CcSEcCtD
Bosutinib—Discomfort—Timolol—hypertension	2.89e-05	0.000193	CcSEcCtD
Bosutinib—Rash—Doxazosin—hypertension	2.89e-05	0.000193	CcSEcCtD
Bosutinib—Fatigue—Losartan—hypertension	2.89e-05	0.000193	CcSEcCtD
Bosutinib—Dermatitis—Doxazosin—hypertension	2.89e-05	0.000193	CcSEcCtD
Bosutinib—Gastrointestinal pain—Hydrochlorothiazide—hypertension	2.88e-05	0.000192	CcSEcCtD
Bosutinib—Vomiting—Fosinopril—hypertension	2.88e-05	0.000192	CcSEcCtD
Bosutinib—Malaise—Lisinopril—hypertension	2.88e-05	0.000192	CcSEcCtD
Bosutinib—Nausea—Propranolol—hypertension	2.87e-05	0.000192	CcSEcCtD
Bosutinib—Anaphylactic shock—Ramipril—hypertension	2.87e-05	0.000192	CcSEcCtD
Bosutinib—Oedema—Ramipril—hypertension	2.87e-05	0.000192	CcSEcCtD
Bosutinib—Headache—Doxazosin—hypertension	2.87e-05	0.000191	CcSEcCtD
Bosutinib—Pain—Losartan—hypertension	2.86e-05	0.000191	CcSEcCtD
Bosutinib—Vomiting—Eplerenone—hypertension	2.86e-05	0.000191	CcSEcCtD
Bosutinib—Feeling abnormal—Furosemide—hypertension	2.86e-05	0.000191	CcSEcCtD
Bosutinib—Leukopenia—Lisinopril—hypertension	2.85e-05	0.00019	CcSEcCtD
Bosutinib—Rash—Fosinopril—hypertension	2.85e-05	0.00019	CcSEcCtD
Bosutinib—Dermatitis—Fosinopril—hypertension	2.85e-05	0.00019	CcSEcCtD
Bosutinib—Vomiting—Nifedipine—hypertension	2.84e-05	0.000189	CcSEcCtD
Bosutinib—Gastrointestinal pain—Furosemide—hypertension	2.84e-05	0.000189	CcSEcCtD
Bosutinib—Rash—Eplerenone—hypertension	2.84e-05	0.000189	CcSEcCtD
Bosutinib—Urticaria—Perindopril—hypertension	2.83e-05	0.000189	CcSEcCtD
Bosutinib—Headache—Fosinopril—hypertension	2.83e-05	0.000189	CcSEcCtD
Bosutinib—Dermatitis—Eplerenone—hypertension	2.83e-05	0.000189	CcSEcCtD
Bosutinib—Diarrhoea—Valsartan—hypertension	2.83e-05	0.000189	CcSEcCtD
Bosutinib—Asthenia—Clonidine—hypertension	2.83e-05	0.000189	CcSEcCtD
Bosutinib—Feeling abnormal—Betaxolol—hypertension	2.83e-05	0.000189	CcSEcCtD
Bosutinib—Vomiting—Verapamil—hypertension	2.83e-05	0.000189	CcSEcCtD
Bosutinib—Urticaria—Irbesartan—hypertension	2.83e-05	0.000189	CcSEcCtD
Bosutinib—Body temperature increased—Perindopril—hypertension	2.82e-05	0.000188	CcSEcCtD
Bosutinib—Abdominal pain—Perindopril—hypertension	2.82e-05	0.000188	CcSEcCtD
Bosutinib—Diarrhoea—Olmesartan—hypertension	2.82e-05	0.000188	CcSEcCtD
Bosutinib—Headache—Eplerenone—hypertension	2.82e-05	0.000188	CcSEcCtD
Bosutinib—Rash—Nifedipine—hypertension	2.81e-05	0.000188	CcSEcCtD
Bosutinib—Nervous system disorder—Ramipril—hypertension	2.81e-05	0.000188	CcSEcCtD
Bosutinib—Dermatitis—Nifedipine—hypertension	2.81e-05	0.000188	CcSEcCtD
Bosutinib—Abdominal pain—Irbesartan—hypertension	2.81e-05	0.000188	CcSEcCtD
Bosutinib—Body temperature increased—Irbesartan—hypertension	2.81e-05	0.000188	CcSEcCtD
Bosutinib—Thrombocytopenia—Ramipril—hypertension	2.81e-05	0.000188	CcSEcCtD
Bosutinib—Oedema—Timolol—hypertension	2.81e-05	0.000187	CcSEcCtD
Bosutinib—Anaphylactic shock—Timolol—hypertension	2.81e-05	0.000187	CcSEcCtD
Bosutinib—Rash—Verapamil—hypertension	2.8e-05	0.000187	CcSEcCtD
Bosutinib—Urticaria—Hydrochlorothiazide—hypertension	2.8e-05	0.000187	CcSEcCtD
Bosutinib—Dermatitis—Verapamil—hypertension	2.8e-05	0.000187	CcSEcCtD
Bosutinib—Headache—Nifedipine—hypertension	2.8e-05	0.000187	CcSEcCtD
Bosutinib—Pruritus—Clonidine—hypertension	2.79e-05	0.000186	CcSEcCtD
Bosutinib—Body temperature increased—Hydrochlorothiazide—hypertension	2.79e-05	0.000186	CcSEcCtD
Bosutinib—Abdominal pain—Hydrochlorothiazide—hypertension	2.79e-05	0.000186	CcSEcCtD
Bosutinib—Skin disorder—Ramipril—hypertension	2.79e-05	0.000186	CcSEcCtD
Bosutinib—Infection—Timolol—hypertension	2.79e-05	0.000186	CcSEcCtD
Bosutinib—Headache—Verapamil—hypertension	2.78e-05	0.000186	CcSEcCtD
Bosutinib—Cough—Lisinopril—hypertension	2.78e-05	0.000186	CcSEcCtD
Bosutinib—Nausea—Diltiazem—hypertension	2.78e-05	0.000185	CcSEcCtD
Bosutinib—Nausea—Indapamide—hypertension	2.78e-05	0.000185	CcSEcCtD
Bosutinib—Asthenia—Trandolapril—hypertension	2.76e-05	0.000184	CcSEcCtD
Bosutinib—Feeling abnormal—Losartan—hypertension	2.76e-05	0.000184	CcSEcCtD
Bosutinib—Urticaria—Furosemide—hypertension	2.76e-05	0.000184	CcSEcCtD
Bosutinib—Nervous system disorder—Timolol—hypertension	2.75e-05	0.000184	CcSEcCtD
Bosutinib—Nausea—Carvedilol—hypertension	2.75e-05	0.000184	CcSEcCtD
Bosutinib—Asthenia—Enalapril—hypertension	2.75e-05	0.000183	CcSEcCtD
Bosutinib—Abdominal pain—Furosemide—hypertension	2.74e-05	0.000183	CcSEcCtD
Bosutinib—Body temperature increased—Furosemide—hypertension	2.74e-05	0.000183	CcSEcCtD
Bosutinib—Gastrointestinal pain—Losartan—hypertension	2.74e-05	0.000183	CcSEcCtD
Bosutinib—Dizziness—Valsartan—hypertension	2.74e-05	0.000183	CcSEcCtD
Bosutinib—Urticaria—Betaxolol—hypertension	2.73e-05	0.000182	CcSEcCtD
Bosutinib—Skin disorder—Timolol—hypertension	2.73e-05	0.000182	CcSEcCtD
Bosutinib—Dizziness—Olmesartan—hypertension	2.72e-05	0.000182	CcSEcCtD
Bosutinib—Pruritus—Trandolapril—hypertension	2.72e-05	0.000182	CcSEcCtD
Bosutinib—Nausea—Doxazosin—hypertension	2.72e-05	0.000182	CcSEcCtD
Bosutinib—Arthralgia—Lisinopril—hypertension	2.71e-05	0.000181	CcSEcCtD
Bosutinib—Myalgia—Lisinopril—hypertension	2.71e-05	0.000181	CcSEcCtD
Bosutinib—Chest pain—Lisinopril—hypertension	2.71e-05	0.000181	CcSEcCtD
Bosutinib—Body temperature increased—Betaxolol—hypertension	2.71e-05	0.000181	CcSEcCtD
Bosutinib—Asthenia—Telmisartan—hypertension	2.71e-05	0.000181	CcSEcCtD
Bosutinib—Pruritus—Enalapril—hypertension	2.71e-05	0.000181	CcSEcCtD
Bosutinib—Diarrhoea—Clonidine—hypertension	2.7e-05	0.00018	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	2.7e-05	0.00018	CcSEcCtD
Bosutinib—Nausea—Fosinopril—hypertension	2.69e-05	0.000179	CcSEcCtD
Bosutinib—Discomfort—Lisinopril—hypertension	2.68e-05	0.000179	CcSEcCtD
Bosutinib—Pruritus—Telmisartan—hypertension	2.67e-05	0.000178	CcSEcCtD
Bosutinib—Nausea—Eplerenone—hypertension	2.67e-05	0.000178	CcSEcCtD
Bosutinib—Urticaria—Losartan—hypertension	2.66e-05	0.000177	CcSEcCtD
Bosutinib—Nausea—Nifedipine—hypertension	2.65e-05	0.000177	CcSEcCtD
Bosutinib—Abdominal pain—Losartan—hypertension	2.65e-05	0.000177	CcSEcCtD
Bosutinib—Body temperature increased—Losartan—hypertension	2.65e-05	0.000177	CcSEcCtD
Bosutinib—Nausea—Verapamil—hypertension	2.64e-05	0.000176	CcSEcCtD
Bosutinib—Asthenia—Captopril—hypertension	2.64e-05	0.000176	CcSEcCtD
Bosutinib—Diarrhoea—Trandolapril—hypertension	2.63e-05	0.000176	CcSEcCtD
Bosutinib—Vomiting—Valsartan—hypertension	2.63e-05	0.000176	CcSEcCtD
Bosutinib—Diarrhoea—Enalapril—hypertension	2.62e-05	0.000175	CcSEcCtD
Bosutinib—Vomiting—Olmesartan—hypertension	2.62e-05	0.000175	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Ramipril—hypertension	2.61e-05	0.000174	CcSEcCtD
Bosutinib—Rash—Valsartan—hypertension	2.61e-05	0.000174	CcSEcCtD
Bosutinib—Dizziness—Clonidine—hypertension	2.61e-05	0.000174	CcSEcCtD
Bosutinib—Dermatitis—Valsartan—hypertension	2.61e-05	0.000174	CcSEcCtD
Bosutinib—Oedema—Lisinopril—hypertension	2.6e-05	0.000174	CcSEcCtD
Bosutinib—Anaphylactic shock—Lisinopril—hypertension	2.6e-05	0.000174	CcSEcCtD
Bosutinib—Pruritus—Captopril—hypertension	2.6e-05	0.000174	CcSEcCtD
Bosutinib—Rash—Olmesartan—hypertension	2.6e-05	0.000173	CcSEcCtD
Bosutinib—Dermatitis—Olmesartan—hypertension	2.59e-05	0.000173	CcSEcCtD
Bosutinib—Headache—Valsartan—hypertension	2.59e-05	0.000173	CcSEcCtD
Bosutinib—Diarrhoea—Telmisartan—hypertension	2.59e-05	0.000173	CcSEcCtD
Bosutinib—Infection—Lisinopril—hypertension	2.59e-05	0.000173	CcSEcCtD
Bosutinib—Headache—Olmesartan—hypertension	2.58e-05	0.000172	CcSEcCtD
Bosutinib—Asthenia—Perindopril—hypertension	2.56e-05	0.000171	CcSEcCtD
Bosutinib—Dyspnoea—Ramipril—hypertension	2.56e-05	0.000171	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Timolol—hypertension	2.56e-05	0.000171	CcSEcCtD
Bosutinib—Asthenia—Irbesartan—hypertension	2.55e-05	0.00017	CcSEcCtD
Bosutinib—Thrombocytopenia—Lisinopril—hypertension	2.55e-05	0.00017	CcSEcCtD
Bosutinib—Dizziness—Trandolapril—hypertension	2.54e-05	0.00017	CcSEcCtD
Bosutinib—Dizziness—Enalapril—hypertension	2.53e-05	0.000169	CcSEcCtD
Bosutinib—Asthenia—Hydrochlorothiazide—hypertension	2.53e-05	0.000169	CcSEcCtD
Bosutinib—Skin disorder—Lisinopril—hypertension	2.53e-05	0.000169	CcSEcCtD
Bosutinib—Pruritus—Perindopril—hypertension	2.52e-05	0.000168	CcSEcCtD
Bosutinib—Pruritus—Irbesartan—hypertension	2.52e-05	0.000168	CcSEcCtD
Bosutinib—Diarrhoea—Captopril—hypertension	2.51e-05	0.000168	CcSEcCtD
Bosutinib—Vomiting—Clonidine—hypertension	2.51e-05	0.000167	CcSEcCtD
Bosutinib—CYP3A4—kidney—hypertension	2.5e-05	0.000257	CbGeAlD
Bosutinib—Dyspnoea—Timolol—hypertension	2.5e-05	0.000167	CcSEcCtD
Bosutinib—Dizziness—Telmisartan—hypertension	2.5e-05	0.000167	CcSEcCtD
Bosutinib—Pruritus—Hydrochlorothiazide—hypertension	2.5e-05	0.000167	CcSEcCtD
Bosutinib—Decreased appetite—Ramipril—hypertension	2.49e-05	0.000166	CcSEcCtD
Bosutinib—Asthenia—Furosemide—hypertension	2.49e-05	0.000166	CcSEcCtD
Bosutinib—Rash—Clonidine—hypertension	2.49e-05	0.000166	CcSEcCtD
Bosutinib—Dermatitis—Clonidine—hypertension	2.48e-05	0.000166	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Ramipril—hypertension	2.48e-05	0.000165	CcSEcCtD
Bosutinib—Fatigue—Ramipril—hypertension	2.47e-05	0.000165	CcSEcCtD
Bosutinib—Headache—Clonidine—hypertension	2.47e-05	0.000165	CcSEcCtD
Bosutinib—Asthenia—Betaxolol—hypertension	2.46e-05	0.000164	CcSEcCtD
Bosutinib—Nausea—Valsartan—hypertension	2.46e-05	0.000164	CcSEcCtD
Bosutinib—Pruritus—Furosemide—hypertension	2.45e-05	0.000164	CcSEcCtD
Bosutinib—Nausea—Olmesartan—hypertension	2.45e-05	0.000163	CcSEcCtD
Bosutinib—Vomiting—Trandolapril—hypertension	2.45e-05	0.000163	CcSEcCtD
Bosutinib—Diarrhoea—Perindopril—hypertension	2.44e-05	0.000163	CcSEcCtD
Bosutinib—Decreased appetite—Timolol—hypertension	2.44e-05	0.000163	CcSEcCtD
Bosutinib—Vomiting—Enalapril—hypertension	2.44e-05	0.000163	CcSEcCtD
Bosutinib—Diarrhoea—Irbesartan—hypertension	2.43e-05	0.000162	CcSEcCtD
Bosutinib—Dizziness—Captopril—hypertension	2.43e-05	0.000162	CcSEcCtD
Bosutinib—Pruritus—Betaxolol—hypertension	2.43e-05	0.000162	CcSEcCtD
Bosutinib—Rash—Trandolapril—hypertension	2.43e-05	0.000162	CcSEcCtD
Bosutinib—Dermatitis—Trandolapril—hypertension	2.42e-05	0.000162	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Timolol—hypertension	2.42e-05	0.000162	CcSEcCtD
Bosutinib—Fatigue—Timolol—hypertension	2.42e-05	0.000161	CcSEcCtD
Bosutinib—Rash—Enalapril—hypertension	2.42e-05	0.000161	CcSEcCtD
Bosutinib—Dermatitis—Enalapril—hypertension	2.41e-05	0.000161	CcSEcCtD
Bosutinib—Diarrhoea—Hydrochlorothiazide—hypertension	2.41e-05	0.000161	CcSEcCtD
Bosutinib—Headache—Trandolapril—hypertension	2.41e-05	0.000161	CcSEcCtD
Bosutinib—Vomiting—Telmisartan—hypertension	2.4e-05	0.00016	CcSEcCtD
Bosutinib—Asthenia—Losartan—hypertension	2.4e-05	0.00016	CcSEcCtD
Bosutinib—Headache—Enalapril—hypertension	2.4e-05	0.00016	CcSEcCtD
Bosutinib—Pain—Timolol—hypertension	2.4e-05	0.00016	CcSEcCtD
Bosutinib—Rash—Telmisartan—hypertension	2.38e-05	0.000159	CcSEcCtD
Bosutinib—Dermatitis—Telmisartan—hypertension	2.38e-05	0.000159	CcSEcCtD
Bosutinib—Diarrhoea—Furosemide—hypertension	2.37e-05	0.000158	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Lisinopril—hypertension	2.37e-05	0.000158	CcSEcCtD
Bosutinib—Pruritus—Losartan—hypertension	2.37e-05	0.000158	CcSEcCtD
Bosutinib—Headache—Telmisartan—hypertension	2.37e-05	0.000158	CcSEcCtD
Bosutinib—Feeling abnormal—Ramipril—hypertension	2.36e-05	0.000158	CcSEcCtD
Bosutinib—Dizziness—Perindopril—hypertension	2.36e-05	0.000157	CcSEcCtD
Bosutinib—Dizziness—Irbesartan—hypertension	2.35e-05	0.000157	CcSEcCtD
Bosutinib—Diarrhoea—Betaxolol—hypertension	2.35e-05	0.000157	CcSEcCtD
Bosutinib—Gastrointestinal pain—Ramipril—hypertension	2.35e-05	0.000157	CcSEcCtD
Bosutinib—Nausea—Clonidine—hypertension	2.34e-05	0.000156	CcSEcCtD
Bosutinib—Vomiting—Captopril—hypertension	2.34e-05	0.000156	CcSEcCtD
Bosutinib—Dizziness—Hydrochlorothiazide—hypertension	2.33e-05	0.000156	CcSEcCtD
Bosutinib—Dyspnoea—Lisinopril—hypertension	2.32e-05	0.000155	CcSEcCtD
Bosutinib—Rash—Captopril—hypertension	2.32e-05	0.000155	CcSEcCtD
Bosutinib—Dermatitis—Captopril—hypertension	2.32e-05	0.000154	CcSEcCtD
Bosutinib—Feeling abnormal—Timolol—hypertension	2.31e-05	0.000154	CcSEcCtD
Bosutinib—Headache—Captopril—hypertension	2.3e-05	0.000154	CcSEcCtD
Bosutinib—Gastrointestinal pain—Timolol—hypertension	2.29e-05	0.000153	CcSEcCtD
Bosutinib—Dizziness—Furosemide—hypertension	2.29e-05	0.000153	CcSEcCtD
Bosutinib—Diarrhoea—Losartan—hypertension	2.29e-05	0.000153	CcSEcCtD
Bosutinib—Nausea—Trandolapril—hypertension	2.29e-05	0.000152	CcSEcCtD
Bosutinib—Urticaria—Ramipril—hypertension	2.28e-05	0.000152	CcSEcCtD
Bosutinib—Nausea—Enalapril—hypertension	2.28e-05	0.000152	CcSEcCtD
Bosutinib—Dizziness—Betaxolol—hypertension	2.27e-05	0.000152	CcSEcCtD
Bosutinib—Vomiting—Perindopril—hypertension	2.27e-05	0.000151	CcSEcCtD
Bosutinib—Body temperature increased—Ramipril—hypertension	2.27e-05	0.000151	CcSEcCtD
Bosutinib—Abdominal pain—Ramipril—hypertension	2.27e-05	0.000151	CcSEcCtD
Bosutinib—Decreased appetite—Lisinopril—hypertension	2.26e-05	0.000151	CcSEcCtD
Bosutinib—Vomiting—Irbesartan—hypertension	2.26e-05	0.000151	CcSEcCtD
Bosutinib—Rash—Perindopril—hypertension	2.25e-05	0.00015	CcSEcCtD
Bosutinib—Dermatitis—Perindopril—hypertension	2.25e-05	0.00015	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Lisinopril—hypertension	2.25e-05	0.00015	CcSEcCtD
Bosutinib—Nausea—Telmisartan—hypertension	2.24e-05	0.00015	CcSEcCtD
Bosutinib—Fatigue—Lisinopril—hypertension	2.24e-05	0.00015	CcSEcCtD
Bosutinib—Vomiting—Hydrochlorothiazide—hypertension	2.24e-05	0.00015	CcSEcCtD
Bosutinib—Rash—Irbesartan—hypertension	2.24e-05	0.00015	CcSEcCtD
Bosutinib—Dermatitis—Irbesartan—hypertension	2.24e-05	0.00015	CcSEcCtD
Bosutinib—Headache—Perindopril—hypertension	2.24e-05	0.000149	CcSEcCtD
Bosutinib—Urticaria—Timolol—hypertension	2.23e-05	0.000149	CcSEcCtD
Bosutinib—Headache—Irbesartan—hypertension	2.23e-05	0.000149	CcSEcCtD
Bosutinib—Pain—Lisinopril—hypertension	2.23e-05	0.000149	CcSEcCtD
Bosutinib—Rash—Hydrochlorothiazide—hypertension	2.22e-05	0.000148	CcSEcCtD
Bosutinib—Dermatitis—Hydrochlorothiazide—hypertension	2.22e-05	0.000148	CcSEcCtD
Bosutinib—Abdominal pain—Timolol—hypertension	2.22e-05	0.000148	CcSEcCtD
Bosutinib—Body temperature increased—Timolol—hypertension	2.22e-05	0.000148	CcSEcCtD
Bosutinib—Dizziness—Losartan—hypertension	2.21e-05	0.000148	CcSEcCtD
Bosutinib—Headache—Hydrochlorothiazide—hypertension	2.21e-05	0.000147	CcSEcCtD
Bosutinib—Vomiting—Furosemide—hypertension	2.21e-05	0.000147	CcSEcCtD
Bosutinib—Rash—Furosemide—hypertension	2.19e-05	0.000146	CcSEcCtD
Bosutinib—Dermatitis—Furosemide—hypertension	2.19e-05	0.000146	CcSEcCtD
Bosutinib—Vomiting—Betaxolol—hypertension	2.18e-05	0.000146	CcSEcCtD
Bosutinib—Nausea—Captopril—hypertension	2.18e-05	0.000146	CcSEcCtD
Bosutinib—Headache—Furosemide—hypertension	2.17e-05	0.000145	CcSEcCtD
Bosutinib—Rash—Betaxolol—hypertension	2.17e-05	0.000144	CcSEcCtD
Bosutinib—Dermatitis—Betaxolol—hypertension	2.16e-05	0.000144	CcSEcCtD
Bosutinib—Headache—Betaxolol—hypertension	2.15e-05	0.000144	CcSEcCtD
Bosutinib—Feeling abnormal—Lisinopril—hypertension	2.14e-05	0.000143	CcSEcCtD
Bosutinib—Gastrointestinal pain—Lisinopril—hypertension	2.13e-05	0.000142	CcSEcCtD
Bosutinib—Vomiting—Losartan—hypertension	2.13e-05	0.000142	CcSEcCtD
Bosutinib—Nausea—Perindopril—hypertension	2.12e-05	0.000141	CcSEcCtD
Bosutinib—Nausea—Irbesartan—hypertension	2.11e-05	0.000141	CcSEcCtD
Bosutinib—Rash—Losartan—hypertension	2.11e-05	0.000141	CcSEcCtD
Bosutinib—Dermatitis—Losartan—hypertension	2.11e-05	0.000141	CcSEcCtD
Bosutinib—Headache—Losartan—hypertension	2.1e-05	0.00014	CcSEcCtD
Bosutinib—Nausea—Hydrochlorothiazide—hypertension	2.1e-05	0.00014	CcSEcCtD
Bosutinib—Urticaria—Lisinopril—hypertension	2.07e-05	0.000138	CcSEcCtD
Bosutinib—Nausea—Furosemide—hypertension	2.06e-05	0.000137	CcSEcCtD
Bosutinib—Asthenia—Ramipril—hypertension	2.06e-05	0.000137	CcSEcCtD
Bosutinib—Abdominal pain—Lisinopril—hypertension	2.06e-05	0.000137	CcSEcCtD
Bosutinib—Body temperature increased—Lisinopril—hypertension	2.06e-05	0.000137	CcSEcCtD
Bosutinib—Nausea—Betaxolol—hypertension	2.04e-05	0.000136	CcSEcCtD
Bosutinib—Pruritus—Ramipril—hypertension	2.03e-05	0.000135	CcSEcCtD
Bosutinib—ABCB1—nephron tubule—hypertension	2.01e-05	0.000207	CbGeAlD
Bosutinib—Asthenia—Timolol—hypertension	2.01e-05	0.000134	CcSEcCtD
Bosutinib—Nausea—Losartan—hypertension	1.99e-05	0.000133	CcSEcCtD
Bosutinib—Pruritus—Timolol—hypertension	1.98e-05	0.000132	CcSEcCtD
Bosutinib—ABCB1—adrenal cortex—hypertension	1.98e-05	0.000204	CbGeAlD
Bosutinib—Diarrhoea—Ramipril—hypertension	1.96e-05	0.000131	CcSEcCtD
Bosutinib—Diarrhoea—Timolol—hypertension	1.92e-05	0.000128	CcSEcCtD
Bosutinib—ABCB1—heart—hypertension	1.92e-05	0.000197	CbGeAlD
Bosutinib—Dizziness—Ramipril—hypertension	1.9e-05	0.000127	CcSEcCtD
Bosutinib—Asthenia—Lisinopril—hypertension	1.87e-05	0.000125	CcSEcCtD
Bosutinib—ABCB1—decidua—hypertension	1.87e-05	0.000191	CbGeAlD
Bosutinib—Dizziness—Timolol—hypertension	1.86e-05	0.000124	CcSEcCtD
Bosutinib—Pruritus—Lisinopril—hypertension	1.84e-05	0.000123	CcSEcCtD
Bosutinib—Vomiting—Ramipril—hypertension	1.82e-05	0.000122	CcSEcCtD
Bosutinib—ABCB1—cardiovascular system—hypertension	1.81e-05	0.000186	CbGeAlD
Bosutinib—Rash—Ramipril—hypertension	1.81e-05	0.000121	CcSEcCtD
Bosutinib—Dermatitis—Ramipril—hypertension	1.81e-05	0.000121	CcSEcCtD
Bosutinib—Headache—Ramipril—hypertension	1.8e-05	0.00012	CcSEcCtD
Bosutinib—Vomiting—Timolol—hypertension	1.78e-05	0.000119	CcSEcCtD
Bosutinib—Diarrhoea—Lisinopril—hypertension	1.78e-05	0.000119	CcSEcCtD
Bosutinib—ABCB1—kidney—hypertension	1.77e-05	0.000182	CbGeAlD
Bosutinib—Rash—Timolol—hypertension	1.77e-05	0.000118	CcSEcCtD
Bosutinib—Dermatitis—Timolol—hypertension	1.77e-05	0.000118	CcSEcCtD
Bosutinib—Headache—Timolol—hypertension	1.76e-05	0.000117	CcSEcCtD
Bosutinib—CYP3A4—endocrine gland—hypertension	1.75e-05	0.00018	CbGeAlD
Bosutinib—ABCB1—cortex of kidney—hypertension	1.72e-05	0.000177	CbGeAlD
Bosutinib—Dizziness—Lisinopril—hypertension	1.72e-05	0.000115	CcSEcCtD
Bosutinib—Nausea—Ramipril—hypertension	1.7e-05	0.000114	CcSEcCtD
Bosutinib—Nausea—Timolol—hypertension	1.67e-05	0.000111	CcSEcCtD
Bosutinib—Vomiting—Lisinopril—hypertension	1.65e-05	0.00011	CcSEcCtD
Bosutinib—Rash—Lisinopril—hypertension	1.64e-05	0.00011	CcSEcCtD
Bosutinib—Dermatitis—Lisinopril—hypertension	1.64e-05	0.000109	CcSEcCtD
Bosutinib—Headache—Lisinopril—hypertension	1.63e-05	0.000109	CcSEcCtD
Bosutinib—CYP3A4—central nervous system—hypertension	1.58e-05	0.000162	CbGeAlD
Bosutinib—ABCB1—medulla oblongata—hypertension	1.55e-05	0.000159	CbGeAlD
Bosutinib—Nausea—Lisinopril—hypertension	1.55e-05	0.000103	CcSEcCtD
Bosutinib—ABCB1—adrenal gland—hypertension	1.43e-05	0.000147	CbGeAlD
Bosutinib—ABCB1—endocrine gland—hypertension	1.24e-05	0.000127	CbGeAlD
Bosutinib—ABCB1—central nervous system—hypertension	1.12e-05	0.000115	CbGeAlD
Bosutinib—CYP3A4—Metabolism—GSTT1—hypertension	1.98e-07	1.18e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC9A1—hypertension	1.98e-07	1.18e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—MYC—hypertension	1.98e-07	1.18e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—hypertension	1.97e-07	1.18e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—hypertension	1.97e-07	1.18e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—RELA—hypertension	1.97e-07	1.18e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ADCY5—hypertension	1.97e-07	1.18e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IGF1—hypertension	1.96e-07	1.18e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AKT2—hypertension	1.96e-07	1.18e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CDKN1A—hypertension	1.96e-07	1.18e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GPX1—hypertension	1.96e-07	1.17e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—PTEN—hypertension	1.96e-07	1.17e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MAPK8—hypertension	1.96e-07	1.17e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—AKT1—hypertension	1.96e-07	1.17e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CETP—hypertension	1.96e-07	1.17e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GCLC—hypertension	1.96e-07	1.17e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—EP300—hypertension	1.95e-07	1.17e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MYC—hypertension	1.95e-07	1.17e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—hypertension	1.94e-07	1.16e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—hypertension	1.94e-07	1.16e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—hypertension	1.94e-07	1.16e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—hypertension	1.94e-07	1.16e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP1A1—hypertension	1.94e-07	1.16e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PRKCA—hypertension	1.94e-07	1.16e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—EP300—hypertension	1.94e-07	1.16e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—hypertension	1.93e-07	1.16e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CDKN1A—hypertension	1.93e-07	1.16e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—hypertension	1.93e-07	1.16e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—PTEN—hypertension	1.93e-07	1.15e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—AKT1—hypertension	1.93e-07	1.15e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MTOR—hypertension	1.93e-07	1.15e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CDKN1A—hypertension	1.92e-07	1.15e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—PTEN—hypertension	1.92e-07	1.15e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MAPK8—hypertension	1.92e-07	1.15e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—EP300—hypertension	1.91e-07	1.14e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CD36—hypertension	1.91e-07	1.14e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—EGFR—hypertension	1.91e-07	1.14e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—MYC—hypertension	1.9e-07	1.14e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SRC—hypertension	1.9e-07	1.14e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—hypertension	1.9e-07	1.14e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—RELA—hypertension	1.89e-07	1.13e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—hypertension	1.89e-07	1.13e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MAPK8—hypertension	1.89e-07	1.13e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—hypertension	1.88e-07	1.13e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MAPK8—hypertension	1.88e-07	1.12e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP17A1—hypertension	1.87e-07	1.12e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—AKT1—hypertension	1.87e-07	1.12e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—hypertension	1.87e-07	1.12e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EP300—hypertension	1.87e-07	1.12e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SERPINE1—hypertension	1.87e-07	1.12e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—EGFR—hypertension	1.86e-07	1.12e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—hypertension	1.86e-07	1.12e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MTOR—hypertension	1.86e-07	1.11e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—AKT1—hypertension	1.86e-07	1.11e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SRC—hypertension	1.85e-07	1.11e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ENO1—hypertension	1.85e-07	1.11e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS1—hypertension	1.85e-07	1.11e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—hypertension	1.85e-07	1.11e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CXCL8—hypertension	1.85e-07	1.11e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—hypertension	1.85e-07	1.11e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EP300—hypertension	1.84e-07	1.1e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EP300—hypertension	1.83e-07	1.1e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—hypertension	1.83e-07	1.1e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—AKT1—hypertension	1.83e-07	1.09e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TP53—hypertension	1.82e-07	1.09e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SRC—hypertension	1.82e-07	1.09e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—hypertension	1.81e-07	1.08e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—hypertension	1.81e-07	1.08e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FGF2—hypertension	1.81e-07	1.08e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RHOA—hypertension	1.8e-07	1.08e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TP53—hypertension	1.79e-07	1.07e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—AKT1—hypertension	1.79e-07	1.07e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—AKT1—hypertension	1.79e-07	1.07e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SRC—hypertension	1.79e-07	1.07e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—EGFR—hypertension	1.79e-07	1.07e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CXCL8—hypertension	1.79e-07	1.07e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—hypertension	1.78e-07	1.07e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CTGF—hypertension	1.78e-07	1.07e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—AKT1—hypertension	1.78e-07	1.07e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PIK3R1—hypertension	1.78e-07	1.07e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOS3—hypertension	1.78e-07	1.07e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SRC—hypertension	1.78e-07	1.07e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARA—hypertension	1.77e-07	1.06e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—hypertension	1.77e-07	1.06e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HMGCR—hypertension	1.77e-07	1.06e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT2—hypertension	1.77e-07	1.06e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—hypertension	1.76e-07	1.06e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—AKT1—hypertension	1.75e-07	1.05e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—hypertension	1.74e-07	1.04e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—AKT1—hypertension	1.74e-07	1.04e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—hypertension	1.73e-07	1.04e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADRA2A—hypertension	1.73e-07	1.04e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—AKT1—hypertension	1.72e-07	1.03e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—hypertension	1.72e-07	1.03e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—AKT1—hypertension	1.72e-07	1.03e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AGT—hypertension	1.72e-07	1.03e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—hypertension	1.71e-07	1.02e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—AKT1—hypertension	1.71e-07	1.02e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MYC—hypertension	1.7e-07	1.02e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TP53—hypertension	1.7e-07	1.02e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—hypertension	1.7e-07	1.02e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CALM1—hypertension	1.69e-07	1.01e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—AKT1—hypertension	1.69e-07	1.01e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—MYC—hypertension	1.69e-07	1.01e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOE—hypertension	1.68e-07	1.01e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—hypertension	1.68e-07	1.01e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RELA—hypertension	1.68e-07	1e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—hypertension	1.68e-07	1e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CDKN1A—hypertension	1.67e-07	1e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAV1—hypertension	1.67e-07	9.99e-07	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—EGFR—hypertension	1.67e-07	9.98e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PTEN—hypertension	1.67e-07	9.98e-07	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—hypertension	1.66e-07	9.96e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOA1—hypertension	1.66e-07	9.96e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MYC—hypertension	1.66e-07	9.96e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—hypertension	1.66e-07	9.93e-07	CbGpPWpGaD
Bosutinib—SRC—Disease—EGFR—hypertension	1.65e-07	9.88e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—AKT1—hypertension	1.65e-07	9.86e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MTOR—hypertension	1.64e-07	9.85e-07	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—hypertension	1.64e-07	9.83e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MAPK8—hypertension	1.63e-07	9.76e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MYC—hypertension	1.63e-07	9.75e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—EGFR—hypertension	1.63e-07	9.74e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—AKT1—hypertension	1.62e-07	9.73e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—hypertension	1.62e-07	9.72e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TH—hypertension	1.62e-07	9.7e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—hypertension	1.61e-07	9.67e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CALM2—hypertension	1.61e-07	9.67e-07	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—hypertension	1.61e-07	9.64e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CDKN1A—hypertension	1.61e-07	9.64e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PTEN—hypertension	1.61e-07	9.61e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MYC—hypertension	1.6e-07	9.6e-07	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TP53—hypertension	1.6e-07	9.59e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—hypertension	1.6e-07	9.57e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MYC—hypertension	1.59e-07	9.55e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EGFR—hypertension	1.59e-07	9.53e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—hypertension	1.59e-07	9.52e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—EP300—hypertension	1.59e-07	9.51e-07	CbGpPWpGaD
Bosutinib—FYN—Disease—AKT1—hypertension	1.59e-07	9.5e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CXCL8—hypertension	1.58e-07	9.47e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—AKT1—hypertension	1.58e-07	9.45e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC2A4—hypertension	1.58e-07	9.44e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GCG—hypertension	1.58e-07	9.44e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MAPK8—hypertension	1.57e-07	9.41e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EGFR—hypertension	1.57e-07	9.39e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EGFR—hypertension	1.56e-07	9.34e-07	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—hypertension	1.56e-07	9.32e-07	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—hypertension	1.55e-07	9.29e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SRC—hypertension	1.54e-07	9.25e-07	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—AKT1—hypertension	1.53e-07	9.19e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EP300—hypertension	1.53e-07	9.17e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT1—hypertension	1.53e-07	9.14e-07	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—AKT1—hypertension	1.51e-07	9.07e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—hypertension	1.5e-07	9.01e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SRC—hypertension	1.49e-07	8.92e-07	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—hypertension	1.49e-07	8.9e-07	CbGpPWpGaD
Bosutinib—EGFR—Immune System—AKT1—hypertension	1.48e-07	8.89e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—STK11—hypertension	1.48e-07	8.88e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP19A1—hypertension	1.48e-07	8.88e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARG—hypertension	1.47e-07	8.78e-07	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—hypertension	1.47e-07	8.78e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—hypertension	1.45e-07	8.68e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—hypertension	1.45e-07	8.66e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—INS—hypertension	1.44e-07	8.61e-07	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—AKT1—hypertension	1.44e-07	8.6e-07	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—hypertension	1.43e-07	8.58e-07	CbGpPWpGaD
Bosutinib—LCK—Immune System—AKT1—hypertension	1.43e-07	8.57e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—hypertension	1.43e-07	8.56e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CDKN1A—hypertension	1.42e-07	8.53e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PTEN—hypertension	1.42e-07	8.51e-07	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TP53—hypertension	1.4e-07	8.38e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MAPK8—hypertension	1.39e-07	8.33e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MYC—hypertension	1.38e-07	8.29e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—hypertension	1.38e-07	8.27e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—COMT—hypertension	1.38e-07	8.25e-07	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—hypertension	1.37e-07	8.22e-07	CbGpPWpGaD
Bosutinib—EGFR—Disease—AKT1—hypertension	1.37e-07	8.21e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TP53—hypertension	1.37e-07	8.18e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARGC1A—hypertension	1.36e-07	8.14e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GNB3—hypertension	1.36e-07	8.14e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EP300—hypertension	1.36e-07	8.12e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HMOX1—hypertension	1.35e-07	8.1e-07	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—AKT1—hypertension	1.35e-07	8.1e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TP53—hypertension	1.34e-07	8.01e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—hypertension	1.33e-07	7.99e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MYC—hypertension	1.33e-07	7.99e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—hypertension	1.33e-07	7.97e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GNAS—hypertension	1.32e-07	7.92e-07	CbGpPWpGaD
Bosutinib—LCK—Disease—AKT1—hypertension	1.32e-07	7.91e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—hypertension	1.32e-07	7.89e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TP53—hypertension	1.32e-07	7.88e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TP53—hypertension	1.31e-07	7.84e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EGFR—hypertension	1.3e-07	7.82e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOB—hypertension	1.3e-07	7.76e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—hypertension	1.28e-07	7.69e-07	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—hypertension	1.28e-07	7.67e-07	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—hypertension	1.27e-07	7.59e-07	CbGpPWpGaD
Bosutinib—SRC—Immune System—AKT1—hypertension	1.27e-07	7.59e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PIK3R1—hypertension	1.26e-07	7.55e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NOS3—hypertension	1.26e-07	7.55e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GSTM1—hypertension	1.26e-07	7.55e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—hypertension	1.25e-07	7.48e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LPL—hypertension	1.24e-07	7.41e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—hypertension	1.22e-07	7.33e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADCY5—hypertension	1.21e-07	7.25e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GPX1—hypertension	1.21e-07	7.23e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—hypertension	1.2e-07	7.21e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—hypertension	1.2e-07	7.18e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PRKCA—hypertension	1.19e-07	7.15e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP1A1—hypertension	1.19e-07	7.15e-07	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—AKT1—hypertension	1.18e-07	7.08e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MYC—hypertension	1.18e-07	7.07e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—hypertension	1.18e-07	7.06e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CD36—hypertension	1.18e-07	7.04e-07	CbGpPWpGaD
Bosutinib—SRC—Disease—AKT1—hypertension	1.17e-07	7e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EGFR—hypertension	1.16e-07	6.92e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—hypertension	1.15e-07	6.91e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—AKT1—hypertension	1.15e-07	6.9e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TP53—hypertension	1.14e-07	6.81e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—AKT1—hypertension	1.13e-07	6.76e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—hypertension	1.11e-07	6.67e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—AKT1—hypertension	1.11e-07	6.66e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—AKT1—hypertension	1.11e-07	6.62e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TP53—hypertension	1.1e-07	6.56e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARA—hypertension	1.09e-07	6.54e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AGT—hypertension	1.06e-07	6.34e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—hypertension	1.04e-07	6.23e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CALM1—hypertension	1.04e-07	6.23e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOE—hypertension	1.04e-07	6.21e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAV1—hypertension	1.03e-07	6.15e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOA1—hypertension	1.02e-07	6.14e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTEN—hypertension	1.01e-07	6.02e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—hypertension	1e-07	6.01e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TP53—hypertension	9.7e-08	5.81e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—AKT1—hypertension	9.6e-08	5.75e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—EP300—hypertension	9.59e-08	5.74e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—AKT1—hypertension	9.25e-08	5.54e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARG—hypertension	9.03e-08	5.41e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—hypertension	8.9e-08	5.33e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—hypertension	8.88e-08	5.32e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—INS—hypertension	8.86e-08	5.3e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AKT1—hypertension	8.19e-08	4.91e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—hypertension	8.12e-08	4.86e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PIK3R1—hypertension	7.77e-08	4.65e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NOS3—hypertension	7.77e-08	4.65e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—hypertension	7.1e-08	4.25e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTEN—hypertension	6.19e-08	3.71e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—EP300—hypertension	5.91e-08	3.54e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AKT1—hypertension	5.79e-08	3.47e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AKT1—hypertension	3.57e-08	2.14e-07	CbGpPWpGaD
